BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 22581293)

  • 41. Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.
    Ueda S; Nagai K; Yokota N; Hirose D; Mori H; Noma Y; Doi T; Minakuchi J
    J Artif Organs; 2019 Sep; 22(3):264-267. PubMed ID: 30805746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between fetuin-A, bone turnover and inflammatory markers concentrations in serum of maintenance hemodialyzed patients.
    Fedak D; Kuźniewski M; Dumnicka P; Kapusta M; Chmiel G; Solnica B; Sułowicz W
    Przegl Lek; 2016; 73(11):799-804. PubMed ID: 29693340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycated albumin versus hemoglobin A1c and mortality in diabetic hemodialysis patients: a cohort study.
    Hoshino J; Hamano T; Abe M; Hasegawa T; Wada A; Ubara Y; Takaichi K; Inaba M; Nakai S; Masakane I;
    Nephrol Dial Transplant; 2018 Jul; 33(7):1150-1158. PubMed ID: 29528439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis.
    Yajima T; Yajima K; Hayashi M; Yasuda K; Takahashi H; Yamakita N
    J Diabetes Complications; 2016 Jul; 30(5):786-9. PubMed ID: 27009773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Bone Turnover Biomarkers in Lead-Battery Workers with Long-Term Exposure to Lead.
    Kalahasthi R; Barman T; Bagepally BS
    Int J Occup Environ Med; 2020 Jul; 11(3):140-147. PubMed ID: 32683426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients.
    Chao TY; Ho CL; Lee SH; Chen MM; Janckila A; Yam LT
    J Biomed Sci; 2004; 11(4):511-6. PubMed ID: 15153786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
    Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher serum bone alkaline phosphatase as a predictor of mortality in male hemodialysis patients.
    Kobayashi I; Shidara K; Okuno S; Yamada S; Imanishi Y; Mori K; Ishimura E; Shoji S; Yamakawa T; Inaba M
    Life Sci; 2012 Jan; 90(5-6):212-8. PubMed ID: 22154904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Glycated albumin levels predict long-term survival in diabetic patients undergoing haemodialysis.
    Fukuoka K; Nakao K; Morimoto H; Nakao A; Takatori Y; Arimoto K; Taki M; Wada J; Makino H
    Nephrology (Carlton); 2008 Jun; 13(4):278-83. PubMed ID: 18476915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z; Konieczna M; Wańkowicz Z
    Pol Merkur Lekarski; 2004 Aug; 17(98):138-41. PubMed ID: 15603322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients.
    Ureña P; Hruby M; Ferreira A; Ang KS; de Vernejoul MC
    J Am Soc Nephrol; 1996 Mar; 7(3):506-12. PubMed ID: 8704118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J; Izumi N; Kasahara H; Tagawa H; Chiba T; Nihei H
    Nihon Jinzo Gakkai Shi; 2010; 52(8):1022-8. PubMed ID: 21254698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption.
    Aonuma H; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y
    Tohoku J Exp Med; 2009 Jul; 218(3):201-5. PubMed ID: 19561390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of calcium supplementation on circulating osteocalcin and glycated haemoglobin in older women.
    Lewis JR; Brennan-Speranza TC; Levinger I; Byrnes E; Lim EM; Blekkenhorst LC; Sim M; Hodgson JM; Zhu K; Lim WH; Adams LA; Prince RL
    Osteoporos Int; 2019 Oct; 30(10):2065-2072. PubMed ID: 31342138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of Lowering Dialysate Calcium Concentration on Bone Metabolic Markers in Hemodialysis Patients With Suppressed Serum Parathyroid Hormone: A Preliminary Study.
    Niwa H; Fukasawa H; Ishibuchi K; Kaneko M; Yasuda H; Furuya R
    Ther Apher Dial; 2018 Oct; 22(5):503-508. PubMed ID: 29923680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab].
    Tatekoshi A; Sato T; Ibata S; Hashimoto A; Kamihara Y; Horiguchi H; Ono K; Takada K; Iyama S; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2014 Nov; 55(11):2271-6. PubMed ID: 25501406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).
    Alatalo SL; Ivaska KK; Waguespack SG; Econs MJ; Väänänen HK; Halleen JM
    Clin Chem; 2004 May; 50(5):883-90. PubMed ID: 15016726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.